Events Partner Content Rational Combinations 360° The Conference Forum is delighted to present the 2nd annual Rational Combinations 360°, the only event addressing business aspects, novel clinical trial designs and scientific deve
News Kite keeps pressure on Novartis with CAR-T filing Kite completes filing a day after rival Novartis.
News AZ's Tagrisso gets full US approval in lung cancer Phase 3 data confirmed its efficacy in patients with a certain mutation.
News NHS to axe 18-week ops waiting target Cancer care and mental health to take priority, says health chief.
News Novartis edges ahead in CAR-T race Novartis has filed its CAR-T cell therapy with the FDA, giving it an edge over Kite Pharma and its rival treatment.
News Tesaro's niraparib approved in ovarian cancer Company nabs maintenance therapy use, but problems on breast cancer trial.
Oncology ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o... For years, ADCs have been positioned as an important addition to the oncology toolkit. But, could they eventually replace chemotherapy altogether?
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.